Bioxytran (BIXT) EBITDA (2010 - 2018)
Bioxytran (BIXT) recorded EBITDA of $4,088 in Q2 2018, compared with -$254,035 a year earlier and up 10.7% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) EBITDA (2010 - 2018) Analysis & Trends
On a TTM basis, Bioxytran's EBITDA came in at -$19,057 as of Jun 30, 2018; for FY2017, it came in at -$293,051.
- Across earlier years, EBITDA came in at -$643,651 in FY2016, -$2.04 million in FY2015, -$1.22 million in FY2014 and -$1.92 million in FY2013.
- Quarterly EBITDA has ranged from -$1.9 million in Q2 2015 to $141,696 in Q4 2016 over the past five years.
- Per Business Quant, the preceding three quarters came in at $3,693 (Q1 2018), -$82,049 (Q4 2017) and $55,211 (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 4,088.00 |
| Mar 31, 2018 | 3,693.00 |
| Dec 31, 2017 | -82,049.00 |
| Sep 30, 2017 | 55,211.00 |
| Jun 30, 2017 | -254,035.00 |
| Mar 31, 2017 | -58,273.00 |
| Dec 31, 2016 | 141,696.00 |
| Sep 30, 2016 | -207,353.00 |
| Jun 30, 2016 | -136,496.00 |
| Mar 31, 2016 | -441,498.00 |
| Dec 31, 2015 | -101,769.00 |
| Sep 30, 2015 | -13,606.00 |
| Jun 30, 2015 | -1.90 Mn |
| Mar 31, 2015 | -22,662.00 |
| Dec 31, 2014 | -161,436.00 |
| Sep 30, 2014 | -1.10 Mn |
| Jun 30, 2014 | -41,611.00 |
| Mar 31, 2014 | 80,304.00 |
| Dec 31, 2013 | -77,530.00 |
| Sep 30, 2013 | -252,091.00 |
API Access
Bioxytran EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();